The FDA has expanded the range of approved uses of Vyvanse (lisdexamfetamine dimesylate) for control of binge-eating disorder in adults. According to the media release from the FDA:In binge-eating disorder, patients have recurrent episodes of compulsive overeating during which they consume larger amounts of food than normal and experience the sense that they lack control. … Continue reading FDA Approves Lisdexamfetamine dimesylate (Vyvanse) for Binge Eating Disorder